
Odyssey Therapeutics, Inc.
ODTXHealthcare|Biotechnology|US
$19.23
+0.35 (+1.85%)
Tangible Book / Share
$7.53
Cash / Share
$6.79
Next Earnings Report
Feb 3, 2027
EPS est. -$1.08
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 8, 2026 (424B4). Possible dilution.
Upcoming Data Readouts (1)
Dec 2026
Est. completion
P1Health Volunteers
The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants
NCT07900607n=8
Recent Press Releases
Odyssey Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 4, 2026 · GlobeNewsWire
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
Oct 20, 2026 · GlobeNewsWire
Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026
Oct 6, 2026 · GlobeNewsWire
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
Sep 16, 2026 · GlobeNewsWire
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Aug 26, 2026 · GlobeNewsWire
SEC Filings (33)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Nov 4, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 4, 2026 | 8-K | Material event | DocumentIndex |
| Oct 20, 2026 | 8-K | Material event | DocumentIndex |
| Sep 9, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 4, 2026 | 8-K | Material event | DocumentIndex |
| Jun 23, 2026 | 8-K | Material event | DocumentIndex |
| Jun 17, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jun 17, 2026 | 8-K | Material event | DocumentIndex |
| Jun 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 18, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 18, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 18, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| May 11, 2026 | 8-K | Material event | DocumentIndex |
| May 11, 2026 | S-8 | Employee stock plan | DocumentIndex |
| May 8, 2026 | 424B4 | Offering prospectus | DocumentIndex |
| May 7, 2026 | EFFECT | DocumentIndex | |
| May 7, 2026 | S-1MEF | IPO / offering registration | DocumentIndex |
| May 7, 2026 | CERT | DocumentIndex | |
| May 5, 2026 | 8-A12B | DocumentIndex | |
| May 4, 2026 | S-1/A | IPO / offering registration | DocumentIndex |
| Apr 17, 2026 | S-1 | IPO / offering registration | DocumentIndex |
| Apr 3, 2026 | DRS/A | DocumentIndex | |
| Mar 16, 2026 | DRS/A | DocumentIndex | |
| Feb 6, 2026 | DRS | DocumentIndex | |
| Dec 4, 2025 | D | DocumentIndex | |
| Jun 9, 2025 | RW | DocumentIndex | |
| Jan 17, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Dec 5, 2024 | DRS/A | DocumentIndex | |
| Nov 18, 2024 | DRS/A | DocumentIndex |